Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08331191edf52b8907dd1b18d355982 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2531-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2527-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M21-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
filingDate |
2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cfb82c9fd8141ecf03f579a749a6dd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40287edfe3de7e4fded51658a438afdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d07e6cba7927ec9b4eda4b231966cdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef63f1656b6b43ff53f31c177606bdfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f493a28481e5dc20a29a4490e1d590 |
publicationDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021041555-A1 |
titleOfInvention |
Methods and compositions for culturing alveolar cells |
abstract |
Described herein are methods and compositions for use in expanding alveolar epithelial cells. The methods may include the use of three-dimensional substrates and improved techniques for expansion of the cells. The improved composition for culturing alveolar epithelial cells may include at least one or more of the following: a TGF-ß pathway inhibitor; a Wnt pathway activator; a ROCK inhibitor; an epidermal growth factor (EGF); a keratinocyte growth factor (KGF); and a fetal bovine serum. |
priorityDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |